Skip to search formSkip to main contentSkip to account menu

Buserelin

Known as: Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH, Busereline 
A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH… 
National Institutes of Health

Related topics

Related topics

15 relations
Buserelin AcetateIn Bloodagonistsanalogs & derivatives

Broader (1)

Fertility Agents, Female

Narrower (4)

HOE-766ReceptalSuprecurSuprefact

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Endocrinology: A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization…
: The use of gonadotrophin-releasing hormone (GnRH) agonists to control ovulation induction cycles for in-vitro fertilization… 
1992
1992
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients.
Two women, aged 44 and 29 years, respectively, were admitted to the hospital in early 1987 for recurrent pneumothorax, dyspnea… 
Highly Cited
1988
Highly Cited
1988
Gonadotropin-releasing hormone desensitization preferentially inhibits expression of the luteinizing hormone beta-subunit gene in vivo.
In this study we investigated changes in steady state cytoplasmic mRNA levels for LH subunits in pituitaries of male rats… 
1987
1987
Simultaneous measurement of hormone release and secretagogue binding by individual pituitary cells.
The quantitative relationship between receptor binding and hormone secretion at the single-cell level was investigated in the… 
1986
1986
Effects of gonadotrophin releasing hormone (buserelin) on sheep fertility
An agonist of gonadotrophin releasing hormone (GnRH) improves dairy cow pregnancy rates when injected at an appropriate stage… 
1986
1986
Blockade of pulsatile LH, FSH and testosterone secretion in rams by constant infusion of an LHRH agonist.
Adult Soay rams were infused for 21 days with 50 micrograms buserelin/day, using s.c. implanted osmotic mini-pumps. The… 
1984
1984
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments
Twenty-one premenopausal patients with metastatic breast cancer (unselected for receptor status) were treated during 3–14 months… 
1984
1984
Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
The LH and FSH release-stimulating (experiment 1) and -blocking (experiment 2) effects of LH-releasing hormone (LHRH) and of the… 
1983
1983
Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone.
Twenty-two consecutive patients with newly diagnosed symptomatic, locally advanced or metastatic prostate cancer were treated… 
1982
1982
[Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
This is a report on the intermittent administration of the potent luteinizing hormone-releasing hormone (LH-RH) agonist… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)